• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE BI-EXTENSION SET 15 CM (6 IN) 0.45 ML; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE BI-EXTENSION SET 15 CM (6 IN) 0.45 ML; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 385163
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/26/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd q-syte bi-extension set 15 cm (6 in) 0.45 ml was damaged.The following information was provided by the initial reporter: "when unscrewing the thread of the octopus, it broke off.".
 
Additional Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval: yes.D10: returned to manufacturer on: 2022-01-31.H6: investigation summary: our quality engineer inspected the 1 used sample submitted for evaluation.The reported issue was confirmed upon inspection of the sample.The male connector of the sample is detached, and the missing part has been inserted into the connecta product.Bd determined that the cause of the failure cannot be attributed to our manufacturing process since the failure cannot be replicated in any of our manufacturing steps.The most probable root cause is application of excessive force during use.A device history record review showed no non-conformances associated with this issue during the production of this batch.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.
 
Event or Problem Description
It was reported that bd q-syte bi-extension set 15 cm (6 in) 0.45 ml was damaged.The following information was provided by the initial reporter: "when unscrewing the thread of the octopus, it broke off.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE BI-EXTENSION SET 15 CM (6 IN) 0.45 ML
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key13319654
Report Number9610847-2022-00018
Device Sequence Number13865077
Product Code FPA
UDI-Device Identifier50382903851633
UDI-Public50382903851633
Combination Product (Y/N)N
Initial Reporter CountryNL
PMA/510(K) Number
K142527
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date05/31/2024
Device Model Number385163
Device Catalogue Number385163
Device Lot Number1179455
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/31/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/30/2021
Supplement Date Received by Manufacturer02/22/2022
Initial Report FDA Received Date01/21/2022
Supplement Report FDA Received Date03/10/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/08/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-